Timothy G Murray Selected Research

Retinoblastoma (Glioblastoma, Retinal)

1/2020	Acute Orbital Compromise after Intra-Arterial Chemotherapy in a Complex Retinoblastoma Associated with 13q Deletion Syndrome.
1/2019	Axial length development in children.
1/2017	An international survey of classification and treatment choices for group D retinoblastoma.
1/2017	Giant retinal tear after intra-arterial chemotherapy for advanced unilateral retinoblastoma.
6/2015	Hemorrhage as a sign of treatment failure after intra-arterial chemotherapy in retinoblastoma.
4/2013	Models and discovery strategies for new therapies of retinoblastoma.
2/2012	Retinoblastoma treatment: utilization of the glycolytic inhibitor, 2-deoxy-2-fluoro-D-glucose (2-FG), to target the chemoresistant hypoxic regions in LH(BETA)T(AG) retinal tumors.
1/2012	Retinoblastoma treatment burden and economic cost: impact of age at diagnosis and selection of primary therapy.
1/2012	Retinoblastoma treatment: impact of the glycolytic inhibitor 2-deoxy-d-glucose on molecular genomics expression in LH(BETA)T(AG) retinal tumors.
7/2011	Regional and temporal differences in gene expression of LH(BETA)T(AG) retinoblastoma tumors.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Timothy G Murray Research Topics

Disease

55	Neoplasms (Cancer) 12/2021 - 12/2002
47	Retinoblastoma (Glioblastoma, Retinal) 01/2020 - 03/2002
18	Retinal Detachment (Retinal Detachments) 01/2022 - 10/2002
17	Cataract (Cataracts) 05/2020 - 01/2002
16	Endophthalmitis (Ophthalmia) 01/2021 - 02/2003
16	Retinal Neoplasms 05/2013 - 04/2006
15	Macular Edema 03/2022 - 04/2003
15	Melanoma (Melanoma, Malignant) 01/2021 - 12/2002
12	Uveal melanoma 01/2020 - 10/2003
10	Macular Degeneration (Age-Related Maculopathy) 01/2021 - 01/2002
8	Retinal Telangiectasis 09/2020 - 11/2005
7	Hemorrhage 07/2020 - 08/2003
6	Retinopathy of Prematurity (Retrolental Fibroplasia) 01/2022 - 03/2006
6	Wounds and Injuries (Trauma) 09/2009 - 04/2005
5	Glaucoma 05/2020 - 11/2007
5	Retinal Perforations 01/2017 - 10/2002
5	Hemangioma (Angioma) 01/2014 - 01/2004
5	Hypoxia (Hypoxemia) 04/2013 - 12/2009
4	Neoplasm Metastasis (Metastasis) 09/2021 - 03/2005
4	Retinal Vasculitis 07/2021 - 07/2009
4	Inflammation (Inflammations) 07/2021 - 07/2020
4	Retinal Vein Occlusion 01/2010 - 10/2006
4	Corneal Edema 08/2007 - 10/2002
3	Choroidal Neovascularization 01/2019 - 02/2002
3	von Hippel-Lindau Disease (von Hippel Lindau Disease) 01/2016 - 01/2004
3	Disease Progression 02/2013 - 07/2009
3	Atrophy 01/2013 - 02/2002
3	Proliferative Vitreoretinopathy 03/2010 - 10/2002
2	Toxic Optic Neuropathy 12/2021 - 10/2004
2	Edema (Dropsy) 09/2020 - 04/2015
2	Choroidal Effusions 07/2020 - 08/2003
2	Aphakia 05/2020 - 08/2003
2	Ocular Hypertension (Glaucoma, Suspect) 01/2017 - 01/2012
2	Capillary Hemangioma 01/2016 - 01/2004
2	Choroid Diseases 12/2015 - 11/2010
2	Familial Exudative Vitreoretinopathies 12/2015 - 11/2004
2	Fibrosis (Cirrhosis) 01/2014 - 08/2007
2	Nevus (Nevi) 01/2014 - 10/2008
2	Telangiectasis (Telangiectasia) 01/2014 - 11/2005
2	Ischemia 01/2014 - 03/2008
2	Hemangioblastoma 09/2010 - 01/2009
2	Vitreous Hemorrhage 07/2009 - 01/2002
2	Necrosis 12/2007 - 07/2003
1	Enhanced S-Cone Syndrome 03/2022
1	Birth Weight (Birth Weights) 01/2022

Drug/Important Bio-Agent (IBA)

22	Bevacizumab (Avastin)FDA Link 01/2021 - 03/2008
20	Retinaldehyde (Retinal)IBA 01/2021 - 10/2002
15	beta Subunit Luteinizing HormoneIBA 02/2012 - 04/2006
13	Carboplatin (JM8)FDA LinkGeneric 12/2010 - 02/2004
8	Triamcinolone Acetonide (Azmacort)FDA LinkGeneric 01/2021 - 11/2003
7	Anti-Bacterial Agents (Antibiotics)IBA 07/2021 - 04/2003
7	Melphalan (Alkeran)FDA LinkGeneric 06/2015 - 04/2010
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 07/2010
6	Triamcinolone (Aristocort)FDA Link 07/2020 - 02/2003
6	Deoxyglucose (2 Deoxy D glucose)IBA 02/2016 - 07/2008
5	brolucizumabIBA 07/2021 - 07/2020
5	Pharmaceutical PreparationsIBA 01/2021 - 09/2006
5	IodineIBA 01/2020 - 12/2002
4	Iodine-125IBA 06/2013 - 01/2012
4	anecortave acetateIBA 01/2011 - 04/2006
3	pimonidazoleIBA 12/2010 - 07/2008
3	Angiogenesis InhibitorsIBA 06/2010 - 04/2006
3	perfluorooctaneIBA 03/2010 - 10/2002
2	Fluorescein (Funduscein)FDA LinkGeneric 01/2021 - 01/2019
2	afliberceptIBA 01/2021 - 01/2019
2	Glucose (Dextrose)FDA LinkGeneric 02/2016 - 02/2014
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2016 - 09/2006
2	Protein Isoforms (Isoforms)IBA 02/2014 - 12/2008
2	Eosine Yellowish-(YS) (Eosin)IBA 02/2012 - 01/2009
2	Hematoxylin (Haematoxylon)IBA 02/2012 - 01/2009
2	SteroidsIBA 01/2012 - 01/2009
2	Ranibizumab (Lucentis)FDA Link 04/2011 - 09/2009
2	Vincristine (Oncovin)FDA LinkGeneric 01/2010 - 01/2009
2	Proteins (Proteins, Gene)FDA Link 07/2009 - 03/2005
2	Silicone OilsIBA 04/2005 - 09/2003
1	Antineoplastic Agents (Antineoplastics)IBA 12/2021

Therapy/Procedure

37	Therapeutics 03/2022 - 07/2003
30	Drug Therapy (Chemotherapy) 01/2021 - 07/2003
25	Vitrectomy 01/2021 - 01/2002
18	Lasers (Laser) 01/2022 - 02/2002
17	Injections 12/2015 - 01/2005
15	Radiotherapy 01/2014 - 03/2002
13	Brachytherapy 09/2021 - 12/2002
12	Intravitreal Injections 01/2021 - 02/2003
11	Laser Therapy (Surgery, Laser) 03/2022 - 03/2006
9	Semiconductor Lasers 09/2020 - 11/2005
8	Aftercare (After-Treatment) 07/2020 - 10/2005
8	Phacoemulsification 01/2015 - 09/2003
7	Intraocular Lenses (Intraocular Lens) 01/2014 - 01/2002
4	Light Coagulation 09/2020 - 07/2004
4	Anesthesia 01/2019 - 07/2012
4	Intraocular Lens Implantation 01/2015 - 09/2003
4	Photochemotherapy (Photodynamic Therapy) 01/2014 - 07/2004
4	Cataract Extraction 10/2013 - 01/2002
3	Intraocular Injections 04/2010 - 04/2006
2	Immunotherapy 12/2021 - 05/2007
2	Palliative Care (Palliative Therapy) 09/2021 - 12/2017
2	Off-Label Use 01/2021 - 03/2008
2	Salvage Therapy 03/2008 - 02/2004
1	Combined Modality Therapy 03/2022